The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease

Eunhye Lee (Seoul, Republic of Korea), Eunhye Lee, Ji Young Hong, Young Ae Kang, Ji Eun Park, Eunkyong Goag

Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Session: Non-tuberculous mycobacteria and molecular microbiology
Session type: Thematic Poster Session
Number: 2677
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eunhye Lee (Seoul, Republic of Korea), Eunhye Lee, Ji Young Hong, Young Ae Kang, Ji Eun Park, Eunkyong Goag. The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease. Eur Respir J 2015; 46: Suppl. 59, 2677

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015

MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Association of serum cytokines with pulmonary tuberculosis treatment outcomes
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible?
Source: International Congress 2015 – Paediatric bronchology
Year: 2015

Non-tuberculous mycobacterial lung diseases: Retrospective analysis of 42 cases
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015

Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016



Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015

Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified?
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Blood and urine IP-10 associate with active TB in HIV-infected patients
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016